The Weight Loss Drug Boom: How It’s Reshaping the Pharmaceutical Landscape and Consumer Brands Worldwide
By 2023, more than 40 companies had joined the GLP-1 drug development race, with more than 60 weight-loss-related molecules in clinical trials worldwide, based on Evaluate Pharma data. Novo Nordisk’s…